// App-Quantinova.ai

P125 : Impact of GvHD-prophylaxis regimen on incidence and severity of gastrointestinal toxicities and acute GvHD after allogeneic HSCT

Researchers

Presenter

  • J. Niestadtkoetter

Principal Investigators

  • L. Mueller

  • C. Mueller-Tidow

  • T. Weber

Medical Centers

  • Klinik fuer Innere Medizin IV, Martin-Luther-Universitaet Halle-Wittenberg, Halle, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Mucositis

  • Graft-versus-host disease

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Cyclosporine A

  • Mycophenolic acid

  • Cyclosporine eent

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved